A connection between gum disease and Alzheimer’s Disease? Yes. Bacteria associated with AD (F. nucleatum – also linked to conditions ranging from colorectal cancer to premature delivery of babies.) -- have been isolated in the periodontal pockets and along the nerves extending from teeth to tissues in the brain. When these bacteria are introduced into brain cultures, an abnormal proliferation of immune (microglial) cells results. The over-abundance of immune cells triggers chronic inflammation which appears to be the key determinant in the p
rogressive cognitive decline that occurs during Alzheimer’s disease
Translational research is currently being aimed at blocking the gateway between periodontal disease and not only Alzheimer’s but a host of other diseases linked directly to chronic inflammation, like Type-2 diabetes, heart disease and COPD.
The OraKlenz Oral Care System has been designed in response to this revealing connection.
…with the express purpose of killing inflammatory bacteria at the gum line before it can cause further harm. (Figure A)
Integrated into a patient’s regular hygiene regimen, the OraKlenz Oral Care System – via the application of patented OraKlenz trays and gel -- will measurably eliminate gum disease in a few weeks…while continuing to provide optimum oral and systemic gateway protection when used as part of a regular dentist-prescribed treatment program.
Each individually presc
ribed OraKlenz treatment tray is made to fit snugly and comfortably over teeth and gum tissue. The treatment margin extends below the pocket depth to ensure targeted effectiveness. A light activating touch infuses the specially formulated OraKlenz Gel – 1.7% hydrogen peroxide with an invigorating mint flavor -- deep into troubled pocket areas for 99.8% treatment efficiency. (Figure B)
For patients struggling with the burden of type 2 diabetes, OraKlenz can significantly tip the scales in the establishment and maintenance of optimum blood sugar levels and infection protection.
For the dentist, The OraKlenz System fulfills the potential for significant practice expansion and optimal care support. The at-the-source treatment of bacterial proliferation and the subsequent control and protection provided by such a system will definitely come as a breath of fresh air to a wide range of patients -- those struggling with chronic halitosis and/or gum disease; those faced with the possibility of oral re-infection; those at risk for a recurrence of COVID-19, RSV or a multitude of more serious systemic conditions.
VISIT OUR WEBSITE: www.SMLglobal.com
https://now.tufts.edu/2022/07/11/studying-link-between-gum-disease-and-alzheimers-disease
https://www.nia.nih.gov/news/large-study-links-gum-disease-dementia